Axerion Therapeutics, Inc.

555 Long Wharf Drive
11th Floor
New Haven, CT 06511
203.492.0550
www.axeriontherapeutics.com

Axerion Therapeutics, Inc. is developing disease-modifying therapeutics for the management and treatment of spinal cord injury, stroke recovery, traumatic brain injury and Alzheimer's disease.

Its Nogo Receptor platform has the potential to stimulate regrowth in axons, long cellular fibers that electrically connect one nerve cell to another and play a vital role in supporting neurological function. Axerion’s Prion Protein project is a novel, potential therapeutic approach for patients suffering from Alzheimer’s disease and if successful, could help slow or halt cognitive decline in Alzheimer’s patients.

Click here for careers at Axerion.